25 XP   0   0   10

Atrys Health SL
Buy, Hold or Sell?

Let's analyse Atrys Health SL together

PenkeI guess you are interested in Atrys Health SL. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Atrys Health SL. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Atrys Health SL

I send you an email if I find something interesting about Atrys Health SL.

Quick analysis of Atrys Health SL (30 sec.)










What can you expect buying and holding a share of Atrys Health SL? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
‚ā¨3.91
Expected worth in 1 year
‚ā¨3.36
How sure are you?
45.2%

+ What do you gain per year?

Total Gains per Share
‚ā¨-0.54
Return On Investment
-14.4%

For what price can you sell your share?

Current Price per Share
‚ā¨3.75
Expected price per share
‚ā¨3.7 - ‚ā¨4.48
How sure are you?
50%

1. Valuation of Atrys Health SL (5 min.)




Live pricePrice per Share (EOD)

‚ā¨3.75

Intrinsic Value Per Share

‚ā¨-2.20 - ‚ā¨-2.54

Total Value Per Share

‚ā¨1.70 - ‚ā¨1.37

2. Growth of Atrys Health SL (5 min.)




Is Atrys Health SL growing?

Current yearPrevious yearGrowGrow %
How rich?$319.2m$331.2m-$2.2m-0.7%

How much money is Atrys Health SL making?

Current yearPrevious yearGrowGrow %
Making money-$16.3m-$9.6m-$6.6m-40.8%
Net Profit Margin-19.4%-12.6%--

How much money comes from the company's main activities?

3. Financial Health of Atrys Health SL (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#183 / 994

Most Revenue
#85 / 994

Most Profit
#693 / 994

Most Efficient
#364 / 994

What can you expect buying and holding a share of Atrys Health SL? (5 min.)

Welcome investor! Atrys Health SL's management wants to use your money to grow the business. In return you get a share of Atrys Health SL.

What can you expect buying and holding a share of Atrys Health SL?

First you should know what it really means to hold a share of Atrys Health SL. And how you can make/lose money.

Speculation

The Price per Share of Atrys Health SL is ‚ā¨3.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atrys Health SL.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atrys Health SL, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨3.91. Based on the TTM, the Book Value Change Per Share is ‚ā¨-0.14 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atrys Health SL.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps-0.32-8.5%-0.19-5.1%-0.12-3.1%-0.08-2.1%-0.05-1.4%
Usd Book Value Change Per Share0.102.5%-0.15-3.9%0.236.0%0.195.1%0.143.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.102.5%-0.15-3.9%0.236.0%0.195.1%0.143.6%
Usd Price Per Share3.95-4.92-7.12-6.95-5.13-
Price to Earnings Ratio-3.08--7.33--46.99--35.70-7.57-
Price-to-Total Gains Ratio41.46-3.30-79.37-23.93-4.48-
Price to Book Ratio0.94-1.13-1.73-3.57-4.51-
Price-to-Total Gains Ratio41.46-3.30-79.37-23.93-4.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.037625
Number of shares247
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.150.19
Usd Total Gains Per Share-0.150.19
Gains per Quarter (247 shares)-35.9247.30
Gains per Year (247 shares)-143.70189.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-144-1540189179
20-287-2980378368
30-431-4420568557
40-575-5860757746
50-718-7300946935
60-862-874011351124
70-1006-1018013241313
80-1150-1162015141502
90-1293-1306017031691
100-1437-1450018921880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%9.022.00.029.0%9.022.00.029.0%
Book Value Change Per Share1.02.01.025.0%5.06.01.041.7%9.010.01.045.0%14.016.01.045.2%14.016.01.045.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share1.02.01.025.0%5.06.01.041.7%9.010.01.045.0%14.016.01.045.2%14.016.01.045.2%

Fundamentals of Atrys Health SL

About Atrys Health SL

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. The company was incorporated in 2007 and is headquartered in Madrid, Spain.

Fundamental data was last updated by Penke on 2024-05-26 04:24:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Atrys Health SL.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Atrys Health SL earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • A Net Profit Margin of -27.1%¬†means that¬†€-0.27 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atrys Health SL:

  • The MRQ is -27.1%. The company is making a huge loss. -2
  • The TTM is -19.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-27.1%TTM-19.4%-7.7%
TTM-19.4%YOY-12.6%-6.8%
TTM-19.4%5Y-12.7%-6.7%
5Y-12.7%10Y-7.9%-4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.1%-178.5%+151.4%
TTM-19.4%-223.7%+204.3%
YOY-12.6%-245.1%+232.5%
5Y-12.7%-390.8%+378.1%
10Y-7.9%-503.2%+495.3%
1.1.2. Return on Assets

Shows how efficient Atrys Health SL is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • -3.6% Return on Assets means that¬†Atrys Health SL generated¬†€-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atrys Health SL:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-2.3%-1.3%
TTM-2.3%YOY-1.3%-1.0%
TTM-2.3%5Y-1.2%-1.1%
5Y-1.2%10Y-0.8%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-11.6%+8.0%
TTM-2.3%-11.6%+9.3%
YOY-1.3%-10.9%+9.6%
5Y-1.2%-12.9%+11.7%
10Y-0.8%-14.1%+13.3%
1.1.3. Return on Equity

Shows how efficient Atrys Health SL is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • -7.8% Return on Equity means Atrys Health SL generated €-0.08¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atrys Health SL:

  • The MRQ is -7.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.8%TTM-5.0%-2.8%
TTM-5.0%YOY-2.5%-2.6%
TTM-5.0%5Y-5.6%+0.6%
5Y-5.6%10Y-3.5%-2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.8%-14.0%+6.2%
TTM-5.0%-14.9%+9.9%
YOY-2.5%-13.5%+11.0%
5Y-5.6%-18.2%+12.6%
10Y-3.5%-19.0%+15.5%

1.2. Operating Efficiency of Atrys Health SL.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Atrys Health SL is operating .

  • Measures how much profit Atrys Health SL makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • An Operating Margin of 0.4%¬†means the company generated €0.00 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atrys Health SL:

  • The MRQ is 0.4%. The company is operating inefficient. -1
  • The TTM is -0.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ0.4%TTM-0.2%+0.6%
TTM-0.2%YOY0.1%-0.4%
TTM-0.2%5Y3.3%-3.5%
5Y3.3%10Y3.0%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%-344.0%+344.4%
TTM-0.2%-235.7%+235.5%
YOY0.1%-262.3%+262.4%
5Y3.3%-383.7%+387.0%
10Y3.0%-485.1%+488.1%
1.2.2. Operating Ratio

Measures how efficient Atrys Health SL is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are €1.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Atrys Health SL:

  • The MRQ is 0.996. The company is less efficient in keeping operating costs low.
  • The TTM is 1.003. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.996TTM1.003-0.007
TTM1.003YOY0.878+0.124
TTM1.0035Y0.535+0.467
5Y0.53510Y0.419+0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9963.092-2.096
TTM1.0033.353-2.350
YOY0.8783.564-2.686
5Y0.5354.836-4.301
10Y0.4196.187-5.768

1.3. Liquidity of Atrys Health SL.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 0.97¬†means the company has €0.97 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Atrys Health SL:

  • The MRQ is 0.973. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.972. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.973TTM0.972+0.001
TTM0.972YOY1.089-0.117
TTM0.9725Y1.264-0.291
5Y1.26410Y1.615-0.351
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9733.776-2.803
TTM0.9724.034-3.062
YOY1.0894.978-3.889
5Y1.2645.984-4.720
10Y1.6156.360-4.745
1.3.2. Quick Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • A Quick Ratio of 0.89¬†means the company can pay off €0.89 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atrys Health SL:

  • The MRQ is 0.895. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.832. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.895TTM0.832+0.063
TTM0.832YOY1.024-0.192
TTM0.8325Y1.142-0.310
5Y1.14210Y1.246-0.104
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8953.198-2.303
TTM0.8323.631-2.799
YOY1.0244.843-3.819
5Y1.1425.825-4.683
10Y1.2466.378-5.132

1.4. Solvency of Atrys Health SL.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Atrys Health SL assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Atrys Health SL to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.53¬†means that Atrys Health SL assets are¬†financed with 52.9% credit (debt) and the remaining percentage (100% - 52.9%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Atrys Health SL:

  • The MRQ is 0.529. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.538. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.529TTM0.538-0.010
TTM0.538YOY0.544-0.005
TTM0.5385Y0.643-0.104
5Y0.64310Y0.566+0.077
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5290.336+0.193
TTM0.5380.346+0.192
YOY0.5440.284+0.260
5Y0.6430.367+0.276
10Y0.5660.376+0.190
1.4.2. Debt to Equity Ratio

Measures if Atrys Health SL is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 114.7% means that company has €1.15 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atrys Health SL:

  • The MRQ is 1.147. The company is able to pay all its debts with equity. +1
  • The TTM is 1.173. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.147TTM1.173-0.026
TTM1.173YOY0.802+0.371
TTM1.1735Y17.473-16.300
5Y17.47310Y13.509+3.964
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1470.383+0.764
TTM1.1730.421+0.752
YOY0.8020.371+0.431
5Y17.4730.447+17.026
10Y13.5090.476+13.033

2. Market Valuation of Atrys Health SL

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Atrys Health SL generates.

  • Above 15 is considered overpriced but¬†always compare¬†Atrys Health SL to the¬†Biotechnology industry mean.
  • A PE ratio of -3.08 means the investor is paying €-3.08¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atrys Health SL:

  • The EOD is -3.152. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.085. Based on the earnings, the company is expensive. -2
  • The TTM is -7.331. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.152MRQ-3.085-0.067
MRQ-3.085TTM-7.331+4.247
TTM-7.331YOY-46.991+39.659
TTM-7.3315Y-35.700+28.369
5Y-35.70010Y7.567-43.267
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.152-2.430-0.722
MRQ-3.085-2.865-0.220
TTM-7.331-2.837-4.494
YOY-46.991-3.469-43.522
5Y-35.700-6.135-29.565
10Y7.567-6.468+14.035
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atrys Health SL:

  • The EOD is -42.679. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -41.768. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.199. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-42.679MRQ-41.768-0.910
MRQ-41.768TTM-2.199-39.569
TTM-2.199YOY-15.751+13.552
TTM-2.1995Y-81.530+79.331
5Y-81.53010Y-64.741-16.789
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-42.679-3.057-39.622
MRQ-41.768-3.525-38.243
TTM-2.199-3.610+1.411
YOY-15.751-4.805-10.946
5Y-81.530-7.882-73.648
10Y-64.741-8.461-56.280
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Atrys Health SL is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of 0.94 means the investor is paying €0.94¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Atrys Health SL:

  • The EOD is 0.960. Based on the equity, the company is cheap. +2
  • The MRQ is 0.940. Based on the equity, the company is cheap. +2
  • The TTM is 1.130. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.960MRQ0.940+0.020
MRQ0.940TTM1.130-0.190
TTM1.130YOY1.735-0.605
TTM1.1305Y3.574-2.444
5Y3.57410Y4.510-0.936
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9601.966-1.006
MRQ0.9402.194-1.254
TTM1.1302.227-1.097
YOY1.7352.447-0.712
5Y3.5743.726-0.152
10Y4.5104.199+0.311
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Atrys Health SL compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.089-0.135+253%0.209-58%0.178-50%0.126-30%
Book Value Per Share--3.9054.024-3%4.052-4%2.247+74%1.505+159%
Current Ratio--0.9730.972+0%1.089-11%1.264-23%1.615-40%
Debt To Asset Ratio--0.5290.538-2%0.544-3%0.643-18%0.566-7%
Debt To Equity Ratio--1.1471.173-2%0.802+43%17.473-93%13.509-92%
Dividend Per Share----0%-0%-0%-0%
Eps---0.297-0.179-40%-0.110-63%-0.074-75%-0.048-84%
Free Cash Flow Per Share---0.022-0.059+168%-0.137+525%-0.043+96%-0.031+41%
Free Cash Flow To Equity Per Share--0.138-0.019+113%0.331-58%0.121+14%0.095+45%
Gross Profit Margin--1.0061.018-1%1.036-3%1.031-2%1.020-1%
Intrinsic Value_10Y_max---2.539--------
Intrinsic Value_10Y_min---2.202--------
Intrinsic Value_1Y_max---0.259--------
Intrinsic Value_1Y_min---0.255--------
Intrinsic Value_3Y_max---0.775--------
Intrinsic Value_3Y_min---0.740--------
Intrinsic Value_5Y_max---1.287--------
Intrinsic Value_5Y_min---1.195--------
Market Cap284753640.000+2%278678917.700346656072.415-20%501925749.440-44%490095722.107-43%361959577.819-23%
Net Profit Margin---0.271-0.194-28%-0.126-53%-0.127-53%-0.079-71%
Operating Margin--0.004-0.002+152%0.001+202%0.033-87%0.030-86%
Operating Ratio--0.9961.003-1%0.878+13%0.535+86%0.419+137%
Pb Ratio0.960+2%0.9401.130-17%1.735-46%3.574-74%4.510-79%
Pe Ratio-3.152-2%-3.085-7.331+138%-46.991+1423%-35.700+1057%7.567-141%
Price Per Share3.750+2%3.6704.565-20%6.610-44%6.454-43%4.767-23%
Price To Free Cash Flow Ratio-42.679-2%-41.768-2.199-95%-15.751-62%-81.530+95%-64.741+55%
Price To Total Gains Ratio42.360+2%41.4573.300+1156%79.370-48%23.929+73%4.479+826%
Quick Ratio--0.8950.832+8%1.024-13%1.142-22%1.246-28%
Return On Assets---0.036-0.023-36%-0.013-64%-0.012-66%-0.008-79%
Return On Equity---0.078-0.050-36%-0.025-68%-0.056-28%-0.035-56%
Total Gains Per Share--0.089-0.135+253%0.209-58%0.178-50%0.126-30%
Usd Book Value--319288924.800328987300.050-3%331264251.375-4%183745088.027+74%123046042.181+159%
Usd Book Value Change Per Share--0.095-0.145+253%0.225-58%0.191-50%0.136-30%
Usd Book Value Per Share--4.2054.332-3%4.363-4%2.420+74%1.620+159%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.320-0.192-40%-0.118-63%-0.080-75%-0.052-84%
Usd Free Cash Flow---1795935.600-4821058.838+168%-11223655.388+525%-3526124.453+96%-2281398.860+27%
Usd Free Cash Flow Per Share---0.024-0.063+168%-0.148+525%-0.046+96%-0.033+41%
Usd Free Cash Flow To Equity Per Share--0.148-0.020+113%0.356-58%0.131+14%0.102+45%
Usd Market Cap306594244.188+2%300053590.688373244593.169-20%540423454.422-44%527686063.993-43%389721877.438-23%
Usd Price Per Share4.038+2%3.9514.915-20%7.117-44%6.949-43%5.132-23%
Usd Profit---24318346.200-16369608.450-33%-9698779.013-60%-6767451.526-72%-4360302.612-82%
Usd Revenue--89724641.10081995819.325+9%76152299.250+18%41014063.393+119%27220888.983+230%
Usd Total Gains Per Share--0.095-0.145+253%0.225-58%0.191-50%0.136-30%
 EOD+6 -2MRQTTM+20 -14YOY+9 -255Y+14 -2010Y+15 -19

3.2. Fundamental Score

Let's check the fundamental score of Atrys Health SL based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.152
Price to Book Ratio (EOD)Between0-10.960
Net Profit Margin (MRQ)Greater than0-0.271
Operating Margin (MRQ)Greater than00.004
Quick Ratio (MRQ)Greater than10.895
Current Ratio (MRQ)Greater than10.973
Debt to Asset Ratio (MRQ)Less than10.529
Debt to Equity Ratio (MRQ)Less than11.147
Return on Equity (MRQ)Greater than0.15-0.078
Return on Assets (MRQ)Greater than0.05-0.036
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Atrys Health SL based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.740
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets629,001
Total Liabilities332,457
Total Stockholder Equity289,872
 As reported
Total Liabilities 332,457
Total Stockholder Equity+ 289,872
Total Assets = 629,001

Assets

Total Assets629,001
Total Current Assets100,870
Long-term Assets528,131
Total Current Assets
Cash And Cash Equivalents 41,829
Short-term Investments 348
Net Receivables 50,582
Inventory 1,677
Other Current Assets 6,782
Total Current Assets  (as reported)100,870
Total Current Assets  (calculated)101,218
+/- 348
Long-term Assets
Property Plant Equipment 62,479
Goodwill 275,740
Intangible Assets 174,745
Long-term Assets Other 2,529
Long-term Assets  (as reported)528,131
Long-term Assets  (calculated)515,493
+/- 12,638

Liabilities & Shareholders' Equity

Total Current Liabilities103,642
Long-term Liabilities228,815
Total Stockholder Equity289,872
Total Current Liabilities
Short-term Debt 64,311
Short Long Term Debt 57,869
Accounts payable 19,136
Other Current Liabilities 20,009
Total Current Liabilities  (as reported)103,642
Total Current Liabilities  (calculated)161,325
+/- 57,683
Long-term Liabilities
Long term Debt 162,726
Capital Lease Obligations 40,707
Long-term Liabilities  (as reported)228,815
Long-term Liabilities  (calculated)203,433
+/- 25,382
Total Stockholder Equity
Common Stock760
Accumulated Other Comprehensive Income -130,648
Other Stockholders Equity 420,520
Total Stockholder Equity (as reported)289,872
Total Stockholder Equity (calculated)290,632
+/- 760
Other
Capital Stock760
Cash and Short Term Investments 41,829
Common Stock Shares Outstanding 75,934
Current Deferred Revenue186
Liabilities and Stockholders Equity 629,001
Net Debt 212,171
Net Invested Capital 510,467
Net Working Capital -2,772
Property Plant and Equipment Gross 142,895
Short Long Term Debt Total 254,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
> Total Assets 
0
15,501
0
30,569
0
30,441
0
40,197
0
37,529
0
53,693
0
60,045
0
88,043
0
90,607
0
175,776
0
556,524
0
565,632
0
697,102
704,048
705,281
695,477
695,477
629,001
629,001
629,001629,001695,477695,477705,281704,048697,1020565,6320556,5240175,776090,607088,043060,045053,693037,529040,197030,441030,569015,5010
   > Total Current Assets 
2,166
2,166
7,006
7,006
4,958
4,958
13,400
13,400
14,472
14,472
15,500
15,500
8,099
8,099
18,026
18,026
17,187
17,187
37,264
37,264
83,957
83,957
103,106
103,106
98,347
98,347
101,872
103,105
107,303
107,303
100,870
100,870
100,870100,870107,303107,303103,105101,87298,34798,347103,106103,10683,95783,95737,26437,26417,18717,18718,02618,0268,0998,09915,50015,50014,47214,47213,40013,4004,9584,9587,0067,0062,1662,166
       Cash And Cash Equivalents 
182
182
2,850
2,850
1,104
1,104
9,268
9,268
10,036
10,036
9,763
9,763
1,320
1,320
8,329
8,329
8,175
8,175
17,476
17,476
18,095
18,095
35,126
35,126
35,598
35,598
34,295
34,295
19,840
19,840
41,829
41,829
41,82941,82919,84019,84034,29534,29535,59835,59835,12635,12618,09518,09517,47617,4768,1758,1758,3298,3291,3201,3209,7639,76310,03610,0369,2689,2681,1041,1042,8502,850182182
       Short-term Investments 
50
99
56
179
56
177
7
142
9
397
84
151
84
151
88
439
88
575
152
129
117
272
103
5,441
358
358
1,769
1,549
401
401
554
348
3485544014011,5491,7693583585,441103272117129152575884398815184151843979142717756179569950
       Net Receivables 
0
0
0
0
0
3,498
0
0
0
0
0
0
0
0
9,147
9,147
8,041
8,041
18,667
19,005
60,770
60,770
56,872
56,872
55,871
57,631
55,301
60,767
64,712
69,541
44,626
50,582
50,58244,62669,54164,71260,76755,30157,63155,87156,87256,87260,77060,77019,00518,6678,0418,0419,1479,147000000003,49800000
       Inventory 
169
169
182
181
237
178
211
208
211
211
259
259
259
259
271
271
493
493
655
655
731
731
793
793
936
936
1,213
1,213
1,571
1,571
1,677
1,677
1,6771,6771,5711,5711,2131,213936936793793731731655655493493271271259259259259211211208211178237181182169169
   > Long-term Assets 
18,305
23,250
5,293
23,564
5,913
25,484
5,581
26,797
5,784
23,058
14,407
38,193
26,668
51,946
44,491
70,017
47,010
73,420
114,046
138,512
437,893
472,567
426,789
462,526
561,476
598,755
602,176
602,176
588,174
588,174
528,131
528,131
528,131528,131588,174588,174602,176602,176598,755561,476462,526426,789472,567437,893138,512114,04673,42047,01070,01744,49151,94626,66838,19314,40723,0585,78426,7975,58125,4845,91323,5645,29323,25018,305
       Property Plant Equipment 
2,970
2,970
2,755
2,755
2,708
2,708
2,571
2,571
2,933
2,415
3,089
2,648
4,093
3,394
7,585
5,738
10,112
8,531
12,328
9,843
63,702
43,643
62,538
62,538
64,208
64,208
69,331
69,331
65,112
65,112
62,479
62,479
62,47962,47965,11265,11269,33169,33164,20864,20862,53862,53843,64363,7029,84312,3288,53110,1125,7387,5853,3944,0932,6483,0892,4152,9332,5712,5712,7082,7082,7552,7552,9702,970
       Goodwill 
1,841
1,841
1,744
1,744
1,648
1,648
1,938
1,550
1,938
1,938
10,095
10,095
21,159
21,159
35,460
35,460
35,460
35,460
71,490
95,051
249,259
249,259
235,836
235,836
304,154
304,154
306,212
306,212
305,847
305,847
275,740
275,740
275,740275,740305,847305,847306,212306,212304,154304,154235,836235,836249,259249,25995,05171,49035,46035,46035,46035,46021,15921,15910,09510,0951,9381,9381,5501,9381,6481,6481,7441,7441,8411,841
       Intangible Assets 
13,437
13,437
716
13,649
749
14,289
984
15,177
825
10,428
1,122
17,009
1,269
17,911
1,412
19,542
1,404
19,786
30,131
26,482
122,638
165,820
127,611
151,132
192,225
215,918
187,855
212,690
173,593
198,326
149,307
174,745
174,745149,307198,326173,593212,690187,855215,918192,225151,132127,611165,820122,63826,48230,13119,7861,40419,5421,41217,9111,26917,0091,12210,42882515,17798414,28974913,64971613,43713,437
       Other Assets 
4,945
-9,915
18,271
0
19,571
0
21,604
0
17,274
0
23,787
0
25,278
0
25,526
25,526
26,410
26,410
29,661
28,447
34,675
34,675
35,737
35,737
37,279
37,279
37,839
8,874
43,528
43,528
0
0
0043,52843,5288,87437,83937,27937,27935,73735,73734,67534,67528,44729,66126,41026,41025,52625,526025,278023,787017,274021,604019,571018,271-9,9154,945
> Total Liabilities 
15,501
15,501
16,306
16,306
16,146
16,146
21,634
16,899
14,071
14,071
27,250
27,250
33,293
33,293
48,089
48,089
51,509
51,509
109,591
100,448
270,972
270,972
291,653
291,653
352,991
352,991
367,708
367,708
377,587
377,587
339,119
332,457
332,457339,119377,587377,587367,708367,708352,991352,991291,653291,653270,972270,972100,448109,59151,50951,50948,08948,08933,29333,29327,25027,25014,07114,07116,89921,63416,14616,14616,30616,30615,50115,501
   > Total Current Liabilities 
2,933
2,933
4,369
4,369
4,004
4,004
5,259
4,966
3,875
3,875
5,480
5,480
10,970
10,970
9,819
9,819
11,407
11,407
21,410
21,410
67,075
67,075
71,502
71,502
84,825
84,825
100,563
100,563
110,425
110,425
103,642
103,642
103,642103,642110,425110,425100,563100,56384,82584,82571,50271,50267,07567,07521,41021,41011,40711,4079,8199,81910,97010,9705,4805,4803,8753,8754,9665,2594,0044,0044,3694,3692,9332,933
       Short-term Debt 
0
909
0
3,242
0
2,802
0
1,152
0
1,007
0
3,024
0
6,147
0
4,486
0
7,197
0
11,822
0
22,847
0
25,586
0
31,297
23,364
48,255
39,040
44,737
57,869
64,311
64,31157,86944,73739,04048,25523,36431,297025,586022,847011,82207,19704,48606,14703,02401,00701,15202,80203,24209090
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,501
0
11,082
0
17,797
0
15,518
0
25,397
0
23,364
0
39,040
0
57,869
57,869039,040023,364025,397015,518017,797011,08206,50100000000000000000
       Accounts payable 
768
364
925
626
953
619
1,531
970
1,028
1,064
1,194
798
1,962
1,435
1,786
2,000
1,652
907
4,255
4,255
14,553
10,467
10,365
10,365
11,825
11,825
15,686
15,686
18,414
18,414
19,136
19,136
19,13619,13618,41418,41415,68615,68611,82511,82510,36510,36510,46714,5534,2554,2559071,6522,0001,7861,4351,9627981,1941,0641,0289701,531619953626925364768
       Other Current Liabilities 
2,165
2,165
3,444
0
3,051
3,051
3,728
3,728
2,848
1,541
4,286
298
9,009
283
8,032
268
9,754
256
17,155
310
52,522
300
61,137
294
73,000
294
61,513
294
52,971
410
26,637
20,009
20,00926,63741052,97129461,51329473,00029461,13730052,52231017,1552569,7542688,0322839,0092984,2861,5412,8483,7283,7283,0513,05103,4442,1652,165
   > Long-term Liabilities 
1,228
12,568
10,265
11,937
10,480
12,143
9,816
11,933
9,250
10,195
14,701
21,771
13,885
22,322
28,873
38,270
30,833
40,102
57,829
79,038
146,877
203,897
146,746
220,151
179,549
268,166
267,145
267,145
267,162
267,162
235,477
228,815
228,815235,477267,162267,162267,145267,145268,166179,549220,151146,746203,897146,87779,03857,82940,10230,83338,27028,87322,32213,88521,77114,70110,1959,25011,9339,81612,14310,48011,93710,26512,5681,228
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,597
0
171,706
0
172,341
0
0
0
0
0000172,3410171,7060136,59700000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,101
8,101
8,194
8,194
19,465
19,465
41,851
41,851
41,283
41,283
57,767
57,767
56,730
56,730
53,218
53,218
0
0
0053,21853,21856,73056,73057,76757,76741,28341,28341,85141,85119,46519,4658,1948,1948,1018,10100000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,284
16,284
16,801
16,801
21,407
21,407
23,122
23,122
23,521
23,521
23,693
23,693
24,835
24,835
24,733
24,733
0
0
0024,73324,73324,83524,83523,69323,69323,52123,52123,12223,12221,40721,40716,80116,80116,28416,28400000000000000
> Total Stockholder Equity
2,540
2,540
1,414
14,263
1,475
14,295
1,568
23,298
2,017
23,459
1,777
26,443
1,924
26,752
152
39,954
-593
39,098
-5,201
75,328
-2,700
285,552
-22,641
274,030
-2,430
344,149
336,397
337,630
318,093
318,093
289,872
289,872
289,872289,872318,093318,093337,630336,397344,149-2,430274,030-22,641285,552-2,70075,328-5,20139,098-59339,95415226,7521,92426,4431,77723,4592,01723,2981,56814,2951,47514,2631,4142,5402,540
   Common Stock
81
81
112
112
112
112
176
176
204
204
216
216
216
216
256
256
256
256
347
347
612
612
614
614
736
736
760
760
760
760
760
760
7607607607607607607367366146146126123473472562562562562162162162162042041761761121121121128181
   Retained Earnings 
2,459
398
1,302
63
1,364
96
1,392
97
1,813
239
1,562
12
1,709
129
-105
-105
-849
-849
-5,548
-2,015
-3,313
-3,313
-23,255
-23,255
-3,166
-3,166
-68,886
-23,259
-65,260
-23,004
-87,861
-45,590
-45,590-87,861-23,004-65,260-23,259-68,886-3,166-3,166-23,255-23,255-3,313-3,313-2,015-5,548-849-849-105-1051291,709121,5622391,813971,392961,364631,3023982,459
   Accumulated Other Comprehensive Income -130,648-42,787-101,871-36,611-82,433-14,780-61,8290000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
315,501
0
405,277
0
420,053
0
0
0
0
0000420,0530405,2770315,50100000000000000000000000
   Treasury Stock00000000000000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue201,569
Cost of Revenue-170,027
Gross Profit31,54231,542
 
Operating Income (+$)
Gross Profit31,542
Operating Expense-27,748
Operating Income3,7943,794
 
Operating Expense (+$)
Research Development3,116
Selling General Administrative6,089
Selling And Marketing Expenses785
Operating Expense27,7489,990
 
Net Interest Income (+$)
Interest Income627
Interest Expense-33,047
Other Finance Cost-0
Net Interest Income-32,420
 
Pretax Income (+$)
Operating Income3,794
Net Interest Income-32,420
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,80638,394
EBIT - interestExpense = -29,253
-45,641
-12,543
Interest Expense33,047
Earnings Before Interest and Taxes (EBIT)3,7942,241
Earnings Before Interest and Taxes (EBITDA)33,467
 
After tax Income (+$)
Income Before Tax-30,806
Tax Provision--2,941
Net Income From Continuing Ops-30,755-27,865
Net Income-45,590
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses197,775
Total Other Income/Expenses Net-34,60032,420
 

Technical Analysis of Atrys Health SL
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atrys Health SL. The general trend of Atrys Health SL is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atrys Health SL's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atrys Health SL.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.05 < 4.37 < 4.48.

The bearish price targets are: 3.71 > 3.7 > 3.7.

Tweet this
Atrys Health SL Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atrys Health SL. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atrys Health SL Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atrys Health SL.

Atrys Health SL Daily Moving Average Convergence/Divergence (MACD) ChartAtrys Health SL Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atrys Health SL. The current adx is .

Atrys Health SL Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atrys Health SL.

Atrys Health SL Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atrys Health SL.

Atrys Health SL Daily Relative Strength Index (RSI) ChartAtrys Health SL Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atrys Health SL.

Atrys Health SL Daily Stochastic Oscillator ChartAtrys Health SL Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atrys Health SL.

Atrys Health SL Daily Commodity Channel Index (CCI) ChartAtrys Health SL Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Atrys Health SL.

Atrys Health SL Daily Chande Momentum Oscillator (CMO) ChartAtrys Health SL Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Atrys Health SL.

Atrys Health SL Daily Williams %R ChartAtrys Health SL Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Atrys Health SL.

Atrys Health SL Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Atrys Health SL.

Atrys Health SL Daily Average True Range (ATR) ChartAtrys Health SL Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Atrys Health SL.